C, R., E, M., R, D., B, Y., J, N., S, B., . . . HC, L. (2025). Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019. The Journal of infectious diseases, 231(3), 677. https://doi.org/10.1093/infdis/jiae452
Chicago Style (17th ed.) CitationC, Reilly, et al. "Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019." The Journal of Infectious Diseases 231, no. 3 (2025): 677. https://doi.org/10.1093/infdis/jiae452.
MLA (9th ed.) CitationC, Reilly, et al. "Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019." The Journal of Infectious Diseases, vol. 231, no. 3, 2025, p. 677, https://doi.org/10.1093/infdis/jiae452.